Brand V/S Generic- Value Based Pricing for Pharmaceuticals in India
نویسندگان
چکیده
The pharmaceuticals in its widen scope means drugs, diagnostics and other commodities that are used to treat disease, manage the condition along with tools and system which are used to diagnose the disease [1]. The pharmaceuticals are the result of extensive research effort which is usually governed by the Intellectual Property Rights (IPR). The IPR is protected by registering the pharmaceuticals as patent trademark franchise. The pharmaceuticals which are protected by patents usually for 20 years from the date of registration. The patent period is protected during which no one can else manufacture the products without the permission of the patent holder. The patent holder shall loose the authority over the patent, after the date of patent period gets over. Anybody can make the patented product, including innovator after patent regimen over and sell it in the market such an innovator product is called “Generics” [2].
منابع مشابه
Designing and Identifying the Variables of the Pricing Model for the Company’s Brand Value in Merger and Acquisition Strategies
Strong brands bring numerous benefits for both the companies and their customers such as decreasing purchasing risk and searching cost and increasing the likelihood of repurchasing. It is not presented an applied model for determining the price of this asset in Iran, especially in terms of merger and acquisition. The purpose of this study is to develop a model for pricing brand value in Iran’s ...
متن کاملA numerical approach to solve eighth order boundary value problems by Haar wavelet collocation method
In this paper a robust and accurate algorithm based on Haar wavelet collocation method (HWCM) is proposed for solving eighth order boundary value problems. We used the Haar direct method for calculating multiple integrals of Haar functions. To illustrate the efficiency and accuracy of the concerned method, few examples are considered which arise in the mathematical modeling of fluid dynamics an...
متن کاملThe Comparison of Efficacy of Original Brand Deferoxamine with Generic Iranian Made Deferoxamine in Urinary Iron Excretion in Patients with Thalassemia Major
Background: Deferoxamine mesylate is still the conventional and well-known iron chelator for patients with thalassemia major. However, due to some marketing issues the well-known original brand, Desferal®, produced by Novartis Pharmaceuticals Company is not as available as before. The generic brands of Deferoxamine have been introduced in many parts of the world including Iran; however, they ar...
متن کاملReference pricing of pharmaceuticals.
We consider a therapeutic market with potentially three pharmaceutical firms. Two of the firms offer horizontally differentiated brand-name drugs. One of the brand-name drugs is a new treatment under patent protection that will be introduced if the profits are sufficient to cover the entry costs. The other brand-name drug has already lost its patent and faces competition from a third firm offer...
متن کاملInvestigating the Factors Affecting Customer-Based Brand Equity in Selected Private Hospitals in Tehran and Kerman
Introduction: Branding is one of the most important needs of any organization to survive and improve the quality of provided products and services. Today, branding is also being increasingly used by health organizations and has become one of the important elements for improving the quality of services provided by hospitals as the main body of health services. In the present study, the factor...
متن کامل